Biotron Ltd
ASX:BIT
Biotron Ltd
ASX:BIT
Price:
0.003
AUD
-14.29%
Market Closed
Market Cap:
AU$6.5m
Relative Value
The Relative Value of one
BIT
stock under the Base Case scenario is
0.025
AUD.
Compared to the current market price of 0.003 AUD,
Biotron Ltd
is
Undervalued by 88%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
BIT
Relative Value
Base Case
0.025
AUD
Undervaluation 88%
Multiples Across Competitors
BIT Competitors Multiples
Biotron Ltd Competitors
Biotron Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| AU |
|
Biotron Ltd
ASX:BIT
|
6.5m AUD | 0 | -20.4 | -16.5 | -16.5 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 643 258.8 | -159 901.4 | -194 171.3 | -191 955.6 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
395.5B USD | 6.6 | 168.3 | 16.3 | 23.1 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
198.2B USD | 5.4 | 25.5 | 14.7 | 14.7 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
184.1B USD | 6.3 | 22.7 | 15.4 | 15.4 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
118.1B USD | 10.1 | 32.1 | 23.6 | 24.6 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 094 | -534.3 | -581.8 | -566.3 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
79.5B USD | 5.5 | 17.7 | 14.9 | 17 | |
| AU |
|
CSL Ltd
ASX:CSL
|
89B AUD | 4 | 20.6 | 13.8 | 17.2 | |
| NL |
|
argenx SE
XBRU:ARGX
|
43.4B EUR | 14.3 | 33.7 | 57.5 | 59.1 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.2 | -61.8 | -66.7 | -60.2 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
